SMTL ID : 6mo7.3 (2 other biounits)

N-terminal bromodomain of human BRD2 with N-((4-(3-(N-cyclopentylsulfamoyl)-4-methylphenyl)-3-methylisoxazol-5-yl)methyl)acetamide inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

monomer

Ligands

1 x JWA: N-({4-[3-(cyclopentylsulfamoyl)-4-methylphenyl]-3-methyl-1,2-oxazol-5-yl}methyl)acetamide(Non-covalent)

JWA.1: 14 residues within 4Å: Chain A: W.29, P.30, F.31, Q.33, V.35, L.40, L.42, M.53, D.54, M.80, C.84, N.88, I.94, M.97 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:W.29, A:W.29, A:P.30, A:P.30, A:L.40, A:L.42, A:D.54, A:I.94 Hydrogen bonds: A:P.30, A:N.88

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sperandio, D. et al., Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor. Bioorg. Med. Chem. (2019)

Release Date

2019-01-23

Peptides

Bromodomain-containing protein 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Bromodomain-containing protein 2

Related Entries With Identical Sequence